RETA Short Information, Reata Pharmaceuticals Inc.

Twenty Trading Day Totals
Total Shorted Volume	679,867
Total Actual Volume	5,360,468

Averages
Average Short Volume	33,993
Average Short Percentage	54.60%

Is there a RETA Short Squeeze or Breakout about to happen?

See the RETA Short Analysis for free Sign up or Login

Stock Date	Open Price	Close Price	High	Low	Total Volume	Short Volume	Short Percentage
2020-06-03	140.96	135.42	142.79	134.01	424,552	60,453	59.4033
2020-06-02	140.56	140.33	141.155	134.68	328,320	67,875	68.0083
2020-06-01	143.97	139.91	145.93	139.33	273,588	33,541	50.4892
2020-05-29	148.06	145.32	148.26	139.62	392,807	59,976	53.4541
2020-05-28	152.5	147.24	154.46	146.5	201,457	26,746	60.5579
2020-05-27	159.5	152.78	160	146.465	335,104	54,897	59.1977
2020-05-26	163.26	157.76	163.98	157.3	176,315	22,409	62.9767
2020-05-22	158.94	160	161.1853	156.205	110,672	11,100	37.6475
2020-05-21	158.36	158.36	159.4002	152.62	221,755	28,642	74.0448
2020-05-20	152	157.26	160.065	150.61	200,517	14,510	51.4758
2020-05-19	151.34	150	155.84	150	195,152	20,672	77.5743
2020-05-18	160.46	152.83	162.36	152.54	206,469	21,023	60.6287
2020-05-15	154.42	154.77	156	150.12	191,653	27,382	55.4516
2020-05-14	146.99	153.53	155.98	146.13	220,391	17,912	37.3642
2020-05-13	165.33	150.54	165.5	146.73	410,569	55,132	56.0131
2020-05-12	160	165.54	176.53	160	454,316	54,492	47.1776
2020-05-11	162.13	164.31	166.63	160.44	421,351	28,718	21.1347
2020-05-08	163.25	162.23	163.81	159.64	276,299	31,559	32.3729
2020-05-07	162.61	160.53	162.61	157.54	169,383	19,152	62.5801
2020-05-06	158.95	160.44	164.03	158.35	149,798	23,676	64.4017

Stock Information

Reata Pharmaceuticals Inc. Company Name:

RETA Stock Symbol:

NASDAQ Market:

RETA Short Information, Reata Pharmaceuticals Inc.

Get RETA Alerts

News, Short Squeeze, Breakout and More Instantly...

RETA - Reata Pharmaceuticals, Inc. (RETA) Q1 2020 Earnings Call Transcript

Image source: The Motley Fool. Reata Pharmaceuticals, Inc. (NASDAQ: RETA) Q1 2020 Earnings Call May 11, 2020 , 4:30 p.m. ET Operator Continue reading
RETA - Reata Pharmaceuticals, Inc. (RETA) CEO Warren Huff on Q1 2020 Results - Earnings Call Transcript

Reata Pharmaceuticals, Inc. (RETA) Q1 2020 Earnings Conference Call May 11, 2020, 16:30 ET Company Participants Vineet Jindal - VP, Corporate Communications & Strategy Colin Meyer - Chief Medical Officer & EVP, Product Development Manmeet Soni - CFO & EVP Warren Huf...
RETA - Reata Pharmaceuticals EPS beats by $0.52, beats on revenue

Reata Pharmaceuticals (NASDAQ: RETA ): Q1 Non-GAAP EPS of -$0.89; GAAP EPS of -$1.47 beats by $0.52 . More news on: Reata Pharmaceuticals, Inc., Earnings news and commentary, Healthcare stocks news, Read more ...